Bowel Cancer - Jun 1, 2023 - Precision nutrition and the gut microbiome: the impact of blueberries

Can't see this email? View it online

	Bowel Cancer
	The latest bowel cancer news from News Medical

	Precision nutrition and the gut microbiome: the impact of blueberries Researchers explored the impacts of precision nutrition on gut microbiome variation.

	Makeup of microbiome in a person's tumor varies depending on early or late-onset colorectal cancer Researchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the make-up of the bacteria, fungi and viruses in a person's tumor varied significantly depending on whether they were diagnosed with early-onset disease (age 45 or younger) or late-onset disease (age 65 or older).

			Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

			Curcumin can suppress metastasis of colorectal cancer cells by activating a specific signaling pathway LMU researchers have identified a signaling pathway via which curcumin can suppress the metastasis of colorectal cancer cells.

			Insights into the direction and extent of gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment Researchers performed a meta-analysis to determine the association between intestinal microbiota and Alzheimer’s disease (AD).

	Mental health profoundly impacts inflammatory responses in the body Study uncovered mechanisms by which psychological stress affects bowel inflammation.

	Study shows how IgA acts as a "tuner" to keep the immune system in check IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers.

	Precision nutrition vs. low-fat diet: No significant difference in diabetes management Researchers compare changes in hemoglobin A1c and glycemic variability to understand the impacts of two calorie-restricted weight loss diets.

	Screening delays during the COVID-19 pandemic likely to increase cancer cases Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, placing an increased burden on an already strained healthcare system, according to a new research article published in the Journal of the American College of Surgeons.

	Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023 Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

	Obesity-related cancers take a toll in Southern Africa: Study reveals alarming trends Research analyzes the prevalence and mortality rates of obesity-related cancers in 16 Southern African countries. It identifies leukemia, esophageal cancer, and colon/rectum cancer as leading causes of cancer mortality in males, and breast cancer, leukemia, and esophageal cancer in females.

	Groundbreaking study targets 'jumping genes' in the entire genomes of the human large intestine The Korea Advanced Institute of Science and Technology (KAIST) and their collaborators have conducted a groundbreaking study targeting 'jumping genes' in the entire genomes of the human large intestine.

	Statistical modeling based of Australian native possum excreta identifies locations of Buruli ulcer occurrence in humans The study aimed to predict the future human Buruli ulcer case locations via statistical modelling.

	NIH scientists identify genomic variants that cause rare inflammatory skin disorder Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

	Using synthetic peptides in next-generation inflammatory disease diagnostic assays Conditions like ulcerative colitis and Crohn's disease, which cause inflammation in the body, can be identified or tracked by measuring a protein called calprotectin.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions